©The Author(s) 2025.
World J Virol. Sep 25, 2025; 14(3): 108405
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.108405
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.108405
Table 1 Clinical manifestations of Lassa fever
| Stage | Duration | Symptoms | Description |
| Incubation period | Days 2-21 | Typical asymptomatic | Virus is replicating; no external signs |
| Early stage | Days 1-6 | Fever, sore throat, muscle aches, chest pain, vomiting, diarrhea | Resembles malaria or typhoid; diagnostic confusion common |
| Progression to severe | Days 7-14 | Facial swelling, mucosal bleeding, pleural/pericardial effusion, hypotension, respiratory distress | Indicates systemic involvement and vascular leakage |
| Neurological phase | Advanced (≥ day 10) | Confusion, seizures, encephalopathy | May progress to multiorgan failure |
| Complications | Variable | Hearing loss (up to 30% of survivors), myocarditis, chronic fatigue, spontaneous abortion (pregnancy) | Hearing loss may be permanent; pregnant females are at very high risk |
| Case fatality risk | Severe cases | 15%-20% in hospitalized patients | Higher in late-presenting cases and pregnant females |
| Recovery phase | After 2-3 weeks | Weakness, fatigue, dizziness, depression | Long recovery; some may need audiological or psychological follow-up |
- Citation: Uppala PK, Karanam SK, Kandra NV, Edhi S. Lassa fever: A comprehensive review of virology, clinical management, and global health implications. World J Virol 2025; 14(3): 108405
- URL: https://www.wjgnet.com/2220-3249/full/v14/i3/108405.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i3.108405